Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (1) , 202.e1-202.e13
Abstract
No abstract availableKeywords
Funding Information
- Moulton Charitable Foundation
- Medical Research Council (G0400546)
- Netherlands Organisation of Scientific Research NWO Investments (175.010.2005.011, 911-03-012)
This publication has 105 references indexed in Scilit:
- High-field Magnetic Resonance Imaging of Brain Iron in Alzheimer DiseaseTopics in Magnetic Resonance Imaging, 2006
- Geography of HFE C282Y and H63D MutationsGenetic Testing, 2000
- The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease PatientsThe American Journal of Pathology, 1999
- Increasing striatal iron content associated with normal agingMovement Disorders, 1998
- Transferrin C2, metal binding and Alzheimerʼs diseaseNeuroReport, 1998
- Increased regional brain concentrations of ceruloplasmin in neurodegenerative disordersBrain Research, 1996
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- The Role of Iron in Beta Amyloid ToxicityBiochemical and Biophysical Research Communications, 1995
- Increased frequency of the transferrin C2 subtype in Alzheimerʼs diseaseNeuroReport, 1993
- Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrinsBiochemistry, 1993